These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 24127780

  • 1. Regulation of the high-affinity choline transporter activity and trafficking by its association with cholesterol-rich lipid rafts.
    Cuddy LK, Winick-Ng W, Rylett RJ.
    J Neurochem; 2014 Mar; 128(5):725-40. PubMed ID: 24127780
    [Abstract] [Full Text] [Related]

  • 2. Activity and subcellular trafficking of the sodium-coupled choline transporter CHT is regulated acutely by peroxynitrite.
    Pinthong M, Black SA, Ribeiro FM, Pholpramool C, Ferguson SS, Rylett RJ.
    Mol Pharmacol; 2008 Mar; 73(3):801-12. PubMed ID: 17971421
    [Abstract] [Full Text] [Related]

  • 3. Rapid, transient effects of the protein kinase C activator phorbol 12-myristate 13-acetate on activity and trafficking of the rat high-affinity choline transporter.
    Black SA, Ribeiro FM, Ferguson SS, Rylett RJ.
    Neuroscience; 2010 May 19; 167(3):765-73. PubMed ID: 20167259
    [Abstract] [Full Text] [Related]

  • 4. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function.
    Butchbach ME, Tian G, Guo H, Lin CL.
    J Biol Chem; 2004 Aug 13; 279(33):34388-96. PubMed ID: 15187084
    [Abstract] [Full Text] [Related]

  • 5. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts).
    Waheed AA, Shimada Y, Heijnen HF, Nakamura M, Inomata M, Hayashi M, Iwashita S, Slot JW, Ohno-Iwashita Y.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):4926-31. PubMed ID: 11309501
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of the high-affinity choline transporter by wild-type and Swedish mutant amyloid precursor protein.
    Cuddy LK, Seah C, Pasternak SH, Rylett RJ.
    J Neurochem; 2015 Aug 24; 134(4):769-82. PubMed ID: 25970623
    [Abstract] [Full Text] [Related]

  • 7. Aberrant trafficking of the high-affinity choline transporter in AP-3-deficient mice.
    Misawa H, Fujigaya H, Nishimura T, Moriwaki Y, Okuda T, Kawashima K, Nakata K, Ruggiero AM, Blakely RD, Nakatsu F, Ohno H.
    Eur J Neurosci; 2008 Jun 24; 27(12):3109-17. PubMed ID: 18554297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification and characterization of ML352: a novel, noncompetitive inhibitor of the presynaptic choline transporter.
    Ennis EA, Wright J, Retzlaff CL, McManus OB, Lin Z, Huang X, Wu M, Li M, Daniels JS, Lindsley CW, Hopkins CR, Blakely RD.
    ACS Chem Neurosci; 2015 Mar 18; 6(3):417-27. PubMed ID: 25560927
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
    Parikh V, Apparsundaram S, Kozak R, Richards JB, Sarter M.
    Neuroscience; 2006 Aug 11; 141(1):379-89. PubMed ID: 16675138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance.
    Holmstrand EC, Lund D, Cherian AK, Wright J, Martin RF, Ennis EA, Stanwood GD, Sarter M, Blakely RD.
    Neurochem Int; 2014 Jul 11; 73():217-28. PubMed ID: 24274995
    [Abstract] [Full Text] [Related]

  • 15. The choline transporter resurfaces: new roles for synaptic vesicles?
    Ferguson SM, Blakely RD.
    Mol Interv; 2004 Feb 11; 4(1):22-37. PubMed ID: 14993474
    [Abstract] [Full Text] [Related]

  • 16. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice.
    Bazalakova MH, Wright J, Schneble EJ, McDonald MP, Heilman CJ, Levey AI, Blakely RD.
    Genes Brain Behav; 2007 Jul 11; 6(5):411-24. PubMed ID: 17010154
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes.
    Bang B, Gniadecki R, Gajkowska B.
    Exp Dermatol; 2005 Apr 11; 14(4):266-72. PubMed ID: 15810884
    [Abstract] [Full Text] [Related]

  • 19. Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals.
    Parikh V, Sarter M.
    J Neurochem; 2006 Apr 11; 97(2):488-503. PubMed ID: 16539662
    [Abstract] [Full Text] [Related]

  • 20. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
    Lincoln JE, Boling M, Parikh AN, Yeh Y, Gilchrist DG, Morse LS.
    Invest Ophthalmol Vis Sci; 2006 May 11; 47(5):2172-8. PubMed ID: 16639029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.